SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

Titan Medical Inc. (TITXF)

TITXF RSS Feed
Add TITXF Price Alert      Hide Sticky   Hide Intro
Moderator: glg20, drrc1949, investinthefuture, cptjsd, Longmoney, SPORT19
Search This Board: 
Last Post: 10/17/2017 5:32:12 AM - Followers: 288 - Board type: Free - Posts Today: 1




"Sneak peak at the latest, cutting edge, single port robotic solution, which debuted at our facility this week. @Titan Medical Inc SPORT Surgical System will revolutionize robotic surgery through single incision and multi-articulation while utilizing an ergonomic workstation." - Florida Hospital Nicholson Center



Titan Medical Reports Success With World’s First Gynecologic, Colorectal and Urologic Single Port Robotic Procedures Performed Using Sport Surgical System

Sep 25,2017

TORONTO, ON–(Marketwired – September 25, 2017) – Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), announces the successful completion of the world’s first gynecologic, colorectal and urologic single port robotic procedures using its advanced prototype SPORT Surgical System at the Florida Hospital Nicholson Center in Celebration, Florida. These procedures are the first preclinical feasibility and validation studies intended to support SPORT Surgical System regulatory submissions. A video of selected procedures has been posted on Titan Medical’s website here http://www.titanmedicalinc.com/technology/#videos.

David McNally, President and CEO of Titan Medical, said, “We are thrilled to successfully complete our first preclinical single port robotic procedures within the gynecologic, colorectal and urologic surgical disciplines using a fully-functional SPORT system, on time and on plan. We credit the expertise of the surgeons, along with the professional team at Nicholson Center who worked seamlessly with our product development team to accomplish this milestone within the first week of installation. Under the expert guidance of renowned surgeons Dr. Ricardo Estape, Dr. Eduardo Parra-Davila and Dr. Vipul Patel, we confirmed the feasibility of single port abdominal robotic surgery with our unique multi-articulated robotic instruments and 3D high-definition visualization in a variety of surgical procedures. This is a significant step forward for Titan Medical and validates our belief that single port robotic surgery holds tremendous potential to improve patient outcomes in gynecologic, colorectal and urologic surgery.”

Ricardo Estape, M.D., a robotic gynecologic oncology surgeon from South Miami Gynecology Oncology Group who specializes in robotic single port surgeries, said, “The SPORT Surgical System performed beyond my expectations and I was able to complete a variety of critical surgical tasks with the necessary dexterity and precision through a single incision. The robotic instruments provided the necessary articulation, range of motion and rigidity along with 3D high-definition video on the flat panel monitor that allowed me to complete the surgery in a comfortable posture. This could be a game changer in gynecological surgery.”

Eduardo Parra-Davila, M.D., a robotic colorectal surgeon at Florida Hospital who has trained thousands of surgeons worldwide on robotic surgery, commented, “Single port surgery without robotic assistance is not easy and yet it remains highly beneficial because of the desire to have fewer ports. It’s all about robotic articulation delivered through a single incision that allows for the reach, necessary angles and multi-quadrant access to treat diseases in colorectal surgeries. The SPORT Surgical System has the promise to become a valuable tool for all robotic surgeons looking to do single port surgery in the future.”

Vipul Patel, M.D., a world-renowned robotic urology surgeon from the Global Robotics Institute at Florida Hospital and the only surgeon in the world to have completed 10,000 robotic prostatectomies, said, “Although multi-port robotic prostatectomy is currently the standard of care in urology, single port robotic surgery could be the next frontier in urology and other surgical disciplines. It was exciting for me to use Titan Medical’s SPORT system at Florida Hospital Nicholson Center. The technological capabilities of the SPORT system are very encouraging and the early success in establishing feasibility is an important step in the right direction.”



                                                                                                                             SPORT™ Surgical System

A robotic system like no other!

The SPORT Surgical System is a versatile single incision advanced robotic surgical system that features state-of the-art multi-articulated instruments with single-use replaceable tips, 3D high definition visualization on a flat-screen monitor, ergonomic open workstation and a single-arm mobile patient cart for ease of set up while enabling broad applications of single and multi-quadrant surgeries previously not possible with current robotic solutions.

Titan Medical Inc. is a Canadian public company, headquartered in Toronto, Ontario, that trades on the Toronto Stock Exchange (TMD) and the OTCQX in the United States (TITXF). Titan is developing the SPORT™ (Single Port Orifice Robotic Technology) Surgical System for use in minimally invasive surgery (“MIS”) that is expected to be commercially available in 2019. Titan’s robotic surgical system is being designed to expand robotic surgery into areas that are currently underserviced. This will allow surgeons to perform procedures within small to medium size surgical spaces such as general surgery and cholecystectomy. Currently, the most common medical procedures for which robotic systems are used are hysterectomies and prostatectomies. Titan plans to expand the scope and obtain approval for various surgical procedures as outlined in their Corporate Presentation.   http://www.titanmedicalinc.com/


The SPORT™ Surgical System includes the following:
                        
* a single-port surgeon controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and

* a surgeon workstation that provides the surgeon with an interface to the robotic platform   for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient’s body during MIS procedures.

 

David J. McNally, Chief Executive Officer, Director

 

Mr. McNally joins Titan after serving as the founder, President, CEO and Chairman of the Board of Domain Surgical Inc., founded in 2009, Domain is based in Salt Lake City, Utah. Mr. McNally brings substantial experience in areas of extraordinary leadership skills with all facets of building innovative medical device companies including clinically-focused product design and development, capital formation, regulatory clearance, and commercialization. Mr. McNally earned an MBA from the University of Utah, holds a Bachelor of Science degree in Mechanical Engineering from Lafayette College, Easton, PA and is the co-inventor of more than 30 U.S. and international patents associated with ferromagnetic surgical devices and systems, electromagnetic and ultrasonic sensors, and medical fluid delivery systems





 

                                                                                  Surgeon Advisory Board

Arnold Advincula, MD

Dr. Advincula is Vice-Chair of Women’s Health & Chief of Gynecology at the Sloane Hospital for Women, Columbia University Medical Center/New York Presbyterian Hospital. Formerly, he was Professor of Obstetrics and Gynecology, Director of the Minimally Invasive Surgery Division and Fellowship, and Director of the Endometriosis Center at the University of Michigan. More recently, he was Director of the Center for Specialized Gynecology and Director of the Education Institute at the Nicholson Center, an advanced medical and surgical simulation training facility at Florida Health. He is currently Vice President of the American Association of Gynecologic Laparoscopy and a Member-at-Large for the Society of Gynecologic Surgeons. He is a leader in minimally invasive surgical techniques and one of the world’s most experienced gynecologic robotic surgeons, who has published and taught extensively in the area of minimally invasive surgery, as well as developed surgical instruments that are in use worldwide.

Juliane Bingener-Casey, MD

Dr. Juliane Bingener is Professor of Surgery, Mayo Clinic College of Medicine, and Vice Chair for Quality, Safety and Service in the Mayo Clinic Department of Surgery. She has a joint appointment in the Division of Gastroenterology and Hepatology, which supports her clinical interests in minimally invasive surgery, endoscopy, and gastrointestinal disease. Her research focuses on patient reported outcomes and novel technology in the diagnosis and treatment of these diseases. Dr. Bingener’s previous work included the development of a Natural Orifice Translumenal Endoscopic Surgery (NOTES) technique for using an omental patch to close perforated ulcers. Her ongoing interests focus on the development, study, and implementation of innovative endoscopic and laparoscopic approaches for gastrointestinal diseases.

W. Douglas Boyd, MD

Dr. Boyd is a Professor of Surgery and Director of Robotics and Biosurgery at the University of California Davis. He is Head of Adult Cardiac Surgery and Surgical Director of the Transcatheter Valve Program. He is recognized for his pioneering work in cardiothoracic surgery and for his use of robotic-assisted surgical systems. He specializes in minimally invasive cardiac and robotic-assisted heart surgery. Dr. Boyd completed the world’s first closed-chest, beating-heart coronary artery bypass surgery using a robotic system in 1999. Prior to his appointment as a professor of surgery at UC Davis Health System, Dr. Boyd served as chair of the Department of Cardiothoracic Surgery at the Cleveland Clinic in Florida. As the author of more than 70 peer-reviewed, journal articles, Dr. Boyd’s research interests include cardiac tissue regeneration using extracellular matrix/stem cells, new techniques for robot-assisted minimally invasive coronary artery revascularization, valve surgery and tele-surgery. He is a graduate of Carleton University in Ottawa, Canada and obtained his medical degree from the University of Ottawa, Canada.

Demetrius EM Litwin, MD, MBA, FRCS, FACS, FICS

Dr. Litwin trained in General Surgery at the University of Saskatchewan, and completed a hepatobiliary fellowship at the University of Toronto. He was an early pioneer in laparoscopic surgery, having performed the first laparoscopic cholecystectomy in Western Canada in 1990 and the first laparoscopic colectomy in Canada in 1991. He was a leader in educating a large number of surgeons across Canada in basic and advanced laparoscopic techniques. During the early advent of minimally invasive surgery, he innovated new laparoscopic approaches to the spine and aorta, and he participated in the development of HandPortTM, a hand assist device for laparoscopic surgery. In 1993, Dr. Litwin became the Director of Minimally Invasive Surgery at the University of Toronto. In 1997, he moved to the University of Massachusetts as Chief of Minimally Invasive Surgery. Since 2004, he has been Chairman of Surgery at the University of Massachusetts Medical School and UMass Memorial Medical Center, one of the largest Academic Health Sciences Centers in Massachusetts. There, he continues to practice minimally invasive surgery of the abdomen in addition to his administrative role.

Lee L Swanstrom, MD, FACS

Dr. Swanstrom heads the Division of GI and Minimally Invasive Surgery at the Oregon Clinic and is Director of the Providence Health System’s Complex GI and Foregut Surgery Postgraduate Fellowship Program. In addition, he is Clinical Professor in the Department of Surgery at OHSU, a Director of the American Board of Surgery, and Past President of both the Society of American Gastrointestinal Endoscopic Surgeons (SAGES) and the Fellowship Council (FC). Most recently, he became the Chief Innovations Officer and Director of the Innovations Fellowship at the Institutes des Hôpitalo Universitaires of the University of Strasbourg, France. He is the editor of Surgical Innovation and the author of over 300 scientific papers and 50 book chapters. This has resulted in 13 patents and a successful medical device startup company. He is and has been an investigator on numerous outcomes research studies for new procedures such as Natural Orifice Translumenal Endoscopic Surgery (NOTES) to determine their safety and efficacy for establishing new standards of care. He remains focused on developing innovative approaches to the minimally invasive treatment of foregut and other gastrointestinal disorders.

John Valvo, MD

Dr. Valvo, a practicing surgeon, is the Executive Director of Robotic and Minimally Invasive Surgery at Rochester General Hospital in Rochester, New York, where he formerly was the Chief of Urology. Following a 20-year career performing open surgery, Dr. Valvo founded the robotic surgery program at Rochester General Hospital in early 2004, which currently ranks in the top two percent of robotic surgery volume in the United States. The program has trained over 30 robotic surgeons and enabled the completion of more than 7,000 robotic urology, gynecology, general and colorectal surgeries to date. Dr. Valvo has authored more than 100 scientific articles and helped start many robotic programs in the northeast. His focus on robotic surgery credentialing led to a notable published paper on policy guidelines for robotic surgery. He is a fellow of the American College of Surgeons and American Urological Association, and a member of the Society for Laparoscopic Surgeons. 

 
 

 

 

 

SECURED PATENTS

  Patent #                                                    Title of Invention
1 8,930,027   Force Feedback System
2 8,792,688   Methods, systems and devices for three dimensional input and control methods and systems based thereon
3 8,768,509   Snaking robotic arm with movable shapers
4 8,347,754   Multi articulating robotic instrument
5 8,332,072   Robotic hand controller
6 8,306,656   Method and system for performing medical procedure
7 8,224,485   Snaking robotic arm with movable shapers
8 5,853,394   Catheter
9 5,607,407   Catheter assembly
10 4,785,868   Medical needle and method for making
  PENDING PATENTS
  PUB. APP. NO.  Title
1 20140316435 METHODS, SYSTEMS AND DEVICES FOR THREE DIMENSIONAL INPUT AND CONTROL METHODS AND SYSTEMS BASED THEREON
2 20140276956 APPARATUS AND METHOD FOR CONTROLLING AN END-EFFECTOR ASSEMBLY
3 20140249546 APPARATUS AND METHOD FOR SUPPORTING A ROBOTIC ARM
4 20140230595 APPARATUS AND METHOD FOR CONTROLLING AN END-EFFECTOR ASSEMBLY
5 20130197697 FORCE FEEDBACK SYSTEM
6 20130197538 ROBOTIC HAND CONTROLLER
7 20120253513 SNAKING ROBOTIC ARM WITH MOVABLE SHAPERS
8 20100036393 METHODS, SYSTEMS AND DEVICES FOR THREEDIMENSIONAL INPUT, AND CONTROL METHODS AND SYSTEMS BASED THEREON

   
SureTrader
Interactive Brokers Advertisement
TITXF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#34285  Sticky Note Titan Medical Facebook Group https://www.facebook.com/groups/TitanMedical.info/ SPORT19 03/19/16 10:14:24 AM
#60310   So SP looks like it's gonna take off? Good SPORT19 10/17/17 05:32:12 AM
#60309   Much man love too you ! Hey, Honeycomb777 10/16/17 11:52:39 PM
#60308   Correct...and they are bringing in surgeons by the ORrep8 10/16/17 11:49:33 PM
#60306   If isrg wanted to buy sport, i doubt QuidWilson 10/16/17 09:24:52 PM
#60305   Last post of the day, i hit my limit. SPORT19 10/16/17 09:20:37 PM
#60304   I just posted the plexus development center address, Adrock 10/16/17 09:08:40 PM
#60303   Raleigh 5511 Capital Center Drive Suite 600 Raleigh, NC 27606 Phone: +1 Adrock 10/16/17 09:06:25 PM
#60302   I believe our Plexus development center is in SPORT19 10/16/17 09:05:43 PM
#60301   Sport19 see below don’t we have on of Adrock 10/16/17 08:58:44 PM
#60299   Make that 81 follows now. Truth. Magnetics 10/16/17 06:59:36 PM
#60296   Fowler likely left because he didn't have the SPORT19 10/16/17 05:40:03 PM
#60291   That's encouraging. I dont know what they QuidWilson 10/16/17 04:52:27 PM
#60290   Current robotic surgeons likely won't go backwards to groupercheeks 10/16/17 04:50:05 PM
#60287   Keep in mind this platform has been available SPORT19 10/16/17 04:18:47 PM
#60286   The upside of this could be that it QuidWilson 10/16/17 04:15:16 PM
#60285   Savy surgeons who are paying attentiom will notice QuidWilson 10/16/17 04:00:00 PM
#60284   Senhance and SPORT are so different I don't SPORT19 10/16/17 03:49:14 PM
#60283   Allow me to posit a thought experiment. I know QuidWilson 10/16/17 03:41:41 PM
#60282   Thank you for your hands on experience in BigT82 10/16/17 03:02:41 PM
#60281   Of course! This is excellent news for us, BigT82 10/16/17 03:00:53 PM
#60280   Sport may be Senhance v2.5....! Oddollar 10/16/17 01:30:22 PM
#60279   Just a reminder, McNally has stated on several Flenderson 10/16/17 01:24:36 PM
#60278   Bummer. Figured it would jump as sympathy play. longtermgems 10/16/17 01:18:00 PM
#60277   No lift from the TRXC news ?? Honeycomb777 10/16/17 01:01:01 PM
#60276   We need some news Titan! Maybe they JMAC13 10/16/17 12:32:08 PM
#60275   Omniguide has its FMSealer for tissue and vessel SPORT19 10/16/17 12:15:57 PM
#60274   For division and sealing of vessels you need hopefulinvest 10/16/17 11:42:51 AM
#60273   I attend Nicholson Center labs bi-weekly and have Renaissance18 10/16/17 11:42:48 AM
#60272   Just look at what TRXC is doing today! Slick Mic 10/16/17 11:38:17 AM
#60271   hopefulinvest, do either of these look like 66Mustang 10/16/17 10:44:24 AM
#60270   That's the only real positive here I think. EIT 10/16/17 10:40:21 AM
#60269   I would think we (Titan) would have no Jjerky1 10/16/17 10:31:57 AM
#60268   My opinion of the TRXC system as a hopefulinvest 10/16/17 10:25:19 AM
#60267   200,000+ shares on the bid at .25, not BigT82 10/16/17 10:09:47 AM
#60266   I remember that there was really no pricing bobbysixty 10/16/17 10:02:39 AM
#60265   SPORT technology shrinks the footprint from 3 HUGE SPORT19 10/16/17 10:01:19 AM
#60264   So the four giant pods on the floor 66Mustang 10/16/17 09:52:01 AM
#60263   It’s never been and will eventually fail when bobbysixty 10/16/17 09:10:49 AM
#60262   This doesn't strike me as the next best thing...... https://youtu.be/xNrtydl4K bet kids tuition 10/16/17 09:03:09 AM
#60259   Good morning all, and Happy Monday! Well, to 66Mustang 10/16/17 08:29:16 AM
#60258   I guess that is all one can do Honeycomb777 10/16/17 08:17:31 AM
#60251   Read the PR they put out last week. longtermgems 10/16/17 07:08:13 AM
#60245   Stop living in the past my friend. Focus BigT82 10/15/17 10:59:47 PM
#60242   If Titan had even sub par management during Honeycomb777 10/15/17 09:30:55 PM
#60238   All fair enough, and I don't argue with EIT 10/15/17 08:55:00 PM
#60237   https://finance.yahoo.com/news/transenterix-announces-dismissal-federal-securiti SPORT19 10/15/17 07:22:07 PM
#60236   LTG - serious question...where do the countless numbers Honeycomb777 10/15/17 07:11:43 PM
#60235   JH was a paid shill to keep help Honeycomb777 10/15/17 07:08:15 PM
#60234   Agreed ORrep8 10/15/17 06:51:30 PM
#60233   Been here years we’re going higher this week! Adrock 10/15/17 06:46:09 PM
PostSubject